Overview
Lobbying Costs
10,000€
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
0.2 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
9
Lobbying Costs over the years
-
Info
CureVac SE
EU Transparency Register
798772637872-28 First registered on 17 Apr 2020
Goals / Remit
CureVac is a pioneer in the field of development and production of a completely new class of therapies based on the messenger molecule mRNA. The basic principle underlying the technology is to employ this molecule as data carrier to provide cells with the necessary information required to produce their own active substances to fight diseases themselves.
In the framework of this register the carried-out activities include informing the relevant decision makers in the European institutes about the possibilities of the mRNA technology and how CureVac can contribute with its technology to meet societal needs. Further, CureVac seeks to be informed about the relevant political intentions, initiatives and measures planned in the future.Main EU files targeted
Current activities:
- Interactions regarding the delivery of mRNA therapeuticsAddress
Head Office
Friedrich-Miescher-Str. 15
Tübingen 72076
GERMANYEU Office
Friedrich-Miescher-Str. 15
Tübingen 72076
GERMANYWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 10% 2 Lobbyists (Full time equivalent)
0.2
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Not applicable
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Vaccines Europe (a specialised vaccines group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the innovative pharmaceutical industry in Europe)
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
10,000€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
Name fti consulting Closed year Costs
0€ - 10,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Not applicable
Other activities
None declared
Meetings
Meetings
9 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 30 Nov 2022 Location Brussels Subject Medicines manufacturing and pandemic preparedness Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 02 Mar 2021 Location Videoconference Subject Vaccine production Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 08 Feb 2021 Location webex Subject meeting with Curevac - vaccines DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 31 Jan 2021 Location Videoconference Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists -
Date 06 Jul 2020 Location Video-conferencing Subject CureVac Signature Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Mariya Gabriel (Commissioner)
-
Date 06 Jul 2020 Location Video-conferencing Subject CureVac Signature Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Innovation and Youth Attending - Mariya Gabriel (Commissioner)
-
Date 16 Mar 2020 Location video-conferencing Subject COVID-19 Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Mariya Gabriel (Commissioner)
-
Date 16 Mar 2020 Location Videoconference Subject Videconderence with CureVac representatives on COVID-19 Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
-
Date 16 Mar 2020 Location video-conferencing Subject COVID-19 Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Innovation and Youth Attending - Mariya Gabriel (Commissioner)